Gabriel Hortobagyi
- Cancer Research top 10%
- Breast Cancer Treatment Studies 4
- Oncology top 10%
- Bone health and treatments 5
- HER2/EGFR in Cancer Research 5
- Cancer Treatment and Pharmacology 3
- Peptidase Inhibition and Analysis 2
-
- Radiopharmaceutical Chemistry and Applications 3
- Monoclonal and Polyclonal Antibodies Research 2
-
- Estrogen and related hormone effects 2
- Co-authors
- David ChenSarat ChandarlapatyMaurizio VoiParul PatelAliaksandra SamoilaDaoqi YouPatricia SungJosé Baselga
- Partner nations
- United StatesUnited KingdomAustria
In The Last Decade
Gabriel Hortobagyi
18 papers receiving 665 citations
Peers
Comparison fields: 5 of 61
- Cancer Research 265
- Oncology 437
- Pulmonary and Respiratory Medicine 274
- Radiology, Nuclear Medicine and Imaging 133
- Genetics 142
Countries citing papers authored by Gabriel Hortobagyi
This map shows the geographic impact of Gabriel Hortobagyi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriel Hortobagyi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriel Hortobagyi more than expected).
Fields of papers citing papers by Gabriel Hortobagyi
This network shows the impact of papers produced by Gabriel Hortobagyi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriel Hortobagyi. The network helps show where Gabriel Hortobagyi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gabriel Hortobagyi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 19 | |
| 2 | 2016 | 347 | |
| 3 | 2011 | 2 | |
| 4 | 2005 | 4 | |
| 5 | 2005 | 1 | |
| 6 | 2004 | 26 | |
| 7 | 2003 | 9 | |
| 8 | 2003 | 4 | |
| 9 | 2001 | 6 | |
| 10 | 2001 | 82 | |
| 11 | 2000 | 13 | |
| 12 | 2000 | 1 | |
| 13 | 1998 | 126 | |
| 14 | Textbook of Breast Cancer: A Clinical Guide to Therapy | 1997 | 28 |
| 15 | 1995 | 3 | |
| 16 | 1991 | 11 | |
| 17 | 1987 | 1 | |
| 18 | Sequential continuous infusion with doxorubicin and vinblastine: an effective chemotherapy combination for patients with advanced breast cancer previously treated with cyclophosphamide, methotrexate, 5-FU, vincristine, and prednisone. | 1984 | 7 |
About Gabriel Hortobagyi
Gabriel Hortobagyi is a scholar working on Oncology, Cancer Research, Otorhinolaryngology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 18 papers that have together received 690 indexed citations. Recurring topics across this work include Bone health and treatments (5 papers), HER2/EGFR in Cancer Research (5 papers), Breast Cancer Treatment Studies (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Cancer Treatment and Pharmacology (3 papers), Estrogen and related hormone effects (2 papers), Peptidase Inhibition and Analysis (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Cancer Research (265 citations), Oncology (437 citations), Pulmonary and Respiratory Medicine (274 citations), Radiology, Nuclear Medicine and Imaging (133 citations) and Genetics (142 citations). Gabriel Hortobagyi has collaborated with scholars based in United States, United Kingdom and Austria. Frequent co-authors include David Chen, Sarat Chandarlapaty, Maurizio Voi, Parul Patel, Aliaksandra Samoila, Daoqi You, Patricia Sung, José Baselga, Michael Gnant and Mary Ellen Moynahan. Their work appears in journals such as Cancer, Seminars in Oncology, Journal of Clinical Oncology, JAMA Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.